When was DermaSensor founded?

DermaSensor was founded in 2009 and raised its 1st funding round 9 years after it was founded.

Where is DermaSensor located?

DermaSensor is headquartered in Miami, United States.

How many employees does DermaSensor have?

As of May 31, 2026, the latest employee count at DermaSensor is 35.

Is DermaSensor a funded company?

DermaSensor is a funded company, having raised a total of $65.7M across 7 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Dec 18, 2018.

When was the latest funding round of DermaSensor?

DermaSensor's latest funding was a $***** Series B round on Jun 10, 2026, with participation from 0 investor.

Where does DermaSensor rank among its competitors?

DermaSensor ranks 1st amongst 73 active competitors, of which 23 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was SquareMind, which secured $18M in Apr, 2026.

Who are the top competitors of DermaSensor?

DermaSensor's top competitors include SciBase, SquareMind and Hememics Biotechnologies. Among them, DermaSensor secured the most recent funding round in June, 2026.

DermaSensor - 2026 Company Profile, Team, Funding & Competitors

DermaSensor is a series B company based in Miami (United States), founded in 2009 by Maurice R Ferre. It operates as a Developer of an AI-powered skin cancer detection device. DermaSensor has raised $65.7M in funding from SternAegis Ventures and Ceros Capital Markets. The company has 73 active competitors, including 23 funded and 5 that have exited. Its top competitors include companies like SciBase, SquareMind and Hememics Biotechnologies.

Company Details

Developer of an AI-powered skin cancer detection device. The company offers DermaSensor device that uses a combination of cutting-edge optical spectroscopy and artificial intelligence to promptly analyze suspicious skin lesions. The device shines light bursts on a lesion, captures scattered light spectra, and uses proprietary AI algorithms to assess malignancy risk for melanoma, basal cell carcinoma, and squamous cell carcinoma.

Website: dermasensor.com
Social
Email ID: *****@dermasensor.com
Phone Number: +1 **********

Key Metrics

Founded Year

2009

Location

Miami, United States

Stage

Series B

Total Funding

$65.7M in 7 rounds

Latest Funding Round

Series B, Jun 10, 2026, $*****

Investors

SternAegis Ventures & 12 more

Ranked

1^st among 73 active competitors

Employee Count

35 as on May 31, 2026

Similar Companies

SciBase & 100 more

View DermaSensor's full profile

DermaSensor is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
DERMASENSOR, INC CIN: 270282657 , United States, Active	Dec 31, 1999	-	13 (As on Dec 31, 2024)	-

DermaSensor has raised a total funding of $65.7M over 7 rounds. Its first funding round was on Dec 18, 2018. DermaSensor has 11 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of DermaSensor:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 10, 2026	7683590	Series B	9798496	4853161	6474459	3921600
Oct 02, 2025	3950562	Series B	3139812	5690813	2494555	Pier 70 Ventures & 2 more
Nov 15, 2024	3895961	Series B	4844806	9174590	2512135	4366744

Access funding benchmarks and valuations. Sign up today!

View details of DermaSensor's funding rounds and investors

The founders of DermaSensor is Maurice R Ferre. Cody Simmons is the CEO of DermaSensor.

Here are the details of DermaSensor's key team members:

Maurice R Ferre: Co-Founder of DermaSensor and founder of 2 other companies, DermaSensor and Fastrack Institute. They are also an angel investor in 1 startup.
Cody Simmons: CEO of DermaSensor.

View details of DermaSensor's Founder profiles and Board Members

DermaSensor's employee count trend

DermaSensor has 35 employees as of May 26. Here is DermaSensor's employee count trend over the years:

Uncover DermaSensor's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of DermaSensor include SciBase, SquareMind and Hememics Biotechnologies. Here is the list of Top 10 competitors of DermaSensor, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	DermaSensor 2009, Miami (United States), Series B	Developer of an AI-powered skin cancer detection device	$65.7M	Ceros Capital Markets, Emerald Ocean Ventures ... & 11 others	61/100
2nd	SciBase 1998, Stockholm (Sweden), Public	Provider of POC device for the detection of malignant melanoma	$22.3M	ÖstVäst Advisory AB, Omega Funds & 5 others	59/100
3rd	SquareMind 2019, Paris (France), Seed	Developer of robotic medical equipment for skin cancer detection	$18M	Sonder Capital, Adamed Technology & 7 others	53/100
4th	Hememics Biotechnologies 2009, Gaithersburg (United States), Seed	Developer of techology platform for biopreservation	$4.6M	American Vietnamese Investment Partners, TEDCO ... & 2 others	50/100
5th	Vivosight 2006, Maidstone (United Kingdom), Series B	Provider of optical coherence tomography diagnostic device for dermatology	$8.9M	Smith+Nephew, The Secretary Of State For Energy and Industrial Strategy ... & 122 others	47/100
6th	AI Medical Technology 2020, Stockholm (Sweden), Seed	AI-powered diagnostic solutions for skin cancer detection	$1M	Northern Capsek Ventures, CVX Ventures	47/100
7th	DAMAE Medical 2014, Paris (France), Series A	Developer of imaging diagnostic device for skin cancer	$10M	Partech Partners, Kurma Partners & 5 others	46/100
8th	Zerigo Health 2014, San Diego (United States), Series B	Developer of UVB light therapy devices for monitoring Psoriasis, Vitiligo, and Eczema	$77.9M	7wire Ventures, SV Health Investors & 15 others	45/100
9th	MedLumics 2009, Madrid (Spain), Series E	Developer of biological tissue imaging by using optical coherence tomography	$62.8M	Edmond de Rothschild, VI Partners & 11 others	44/100
10th	Michelson Diagnostics 2006, Maidstone (United Kingdom), Deadpooled	Point-of-care Optical Coherence Tomography(OCT) device for dermatology	$14.9M	Octopus Ventures, Octopus Investments & 79 others	44/100